FDA Adverse Event Injury Summary report: N

DEPUY ASR XL FEM IMP SIZE 49

MDR report key: 2162231 · Received July 7, 2011

Report

Report Number
1818910-2011-12502
Event Type
Injury
Date Received
July 7, 2011
Date of Event
June 8, 2011
Report Date
March 27, 2015
Manufacturer
DEPUY INTERNATIONAL LTD.
Product Code
KWA
PMA / PMN Number
NA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
UNKNOWN

Narratives

Additional Manufacturer Narrative · 1

THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4).

Additional Manufacturer Narrative · 1

THIS COMPLAINT IS STILL UNDER INVESTIGATION. DEPUY WILL NOTIFY THE FDA OF THE RESULTS OF THIS INVESTIGATION ONCE IT HAS BEEN COMPLETED.

Additional Manufacturer Narrative · 1

DEPUY STILL CONSIDERS THE INVESTIGATION CLOSED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.DEPUY STILL CONSIDERS THIS CASE CLOSED TO CAPA.

Description of Event or Problem · 1

REASON FOR REVISION: ALVAL / SOFT TISSUE REACTION.

Description of Event or Problem · 1

(B)(4). ASR REVISION. ASR XL ACETABULAR SYSTEM (RIGHT) UPDATE - ADDED REASON FOR REVISION, SURGEON, TAKEN FROM CLAIMSUITE DATED 20TH MARCH 2013 REASON(S) FOR REVISION: UNKNOWN. UPDATE - ADDED REASON FOR REVISON TAKEN FROM CLAIMSUITE DATED 19TH AUGUST 2013 REASON(S) FOR REVISION: ALVAL / SOFT TISSUE REACTION. UPDATE 24 MAR 2015 - ADDED TAPER SLEEVE AND UNK STEM. (B)(4).

Description of Event or Problem · 1

THE PT HAS HAD AN ASR REVISION. SPECIFIC DETAILS REGARDING THE REPORT ARE UNK.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEPUY ASR XL FEM IMP SIZE 49 HIP FEMORAL HEAD KWA DEPUY INTERNATIONAL LTD. NA 2194761

Patients

Seq Age Sex Outcome Treatment
1 NA Required Intervention